Leadership

  • Jeff R. Swarz, Ph.D - CEO

    32 years of experience in product development, marketing, equity analysis, capital raising, M&A. CEO of Agribiotics (sold to Mobay Chemical Co.). II-rated biotech analyst at Goldman Sachs and Credit Suisse First Boston. Completed post-doctoral fellowship at Johns Hopkins Medical School in Neurology (section Neurovirology), Ph.D. in Neuroscience University of  Rochester;  BSc. (with honors) University of California at Irvine.

  • Joseph Chiarelli, CPA, MBA - CFO

    Former CEO of Sannuwave. Chairman of Clarent Hospital Mgmt. Corp. II All-Star analyst at JP Morgan & Co. (now JPM) in both equities and high-yield research.  CFO of two large subsidiaries of JPM, Manager with Coopers & Lybrand (now PWC); Colonel USAF (ret).

Scientific Advisory Board

  • Dr. Hermona Soreq, Ph.D

    Hebrew University in Jerusalem

    Professor of Molecular Neuroscience, The Edmond and Lily Safra Center for Brain Sciences

  • John J. Foxe, Ph.D.

    University of Rochester

    Director, Ernest J. Del Monte Institute for Neuroscience, Professor and Chair for Department of Neuroscience

  • Roger Barker

    Cambridge Stem Cell Institute

    Neuroscience Clinical Professor, Centre for Brain Repair, Department of Clinical Neuroscience

  • Daphne Atlas

    Hebrew University of Jerusalem

    Professor of Neurochemistry, Department of Biological Chemistry,  Institute of Life Sciences

  • Serge Przedborski MD, Ph.D

    Columbia University Medical Center

    Co-Director, Motor Neuron Center, Vice Chair of Research, Department of Neurology